uniquely, the program reimburses payers should patients not achieve and then maintain weight loss following deprescription, allowing payers to avoid losses
For example, aim to lose 5-10% of your body weight in the first six months
Under-dosing means wasted weeks waiting for results that should have arrived sooner
Plaitakis and Shashidharan 2000)
The largest group, CJC-1295, Ipamorelin, Sermorelin, Hexarelin, Tesamorelin, and MK-677, are growth-hormone secretagogues or GHRH/GHRP analogs
Strategies for managing dose-transition burping: Front-load dietary changes before escalating